Indeed, EPZ-643 and GSK-126, known as EZH2 inhibitors, were shown to sensitize MM cells to HDAC inhibitor panobinostat, favoring MM cell apoptosis and reducing MM cell survival [55]. The gene discussed is EZH2; the disease is Miyoshi myopathy.